NPPB and atrial fibrillation: Patients with CA usually show higher levels of cardiac biomarkers, such as N-terminal brain natriuretic peptide (NT-proBNP) and cardiac troponin (cTn), and specific alterations of the electrocardiogram (ECG) (Figure 1), including atrial fibrillation (AF) (14, 15).